Dynamic Insulin Sensitivity Factor Calculation for Glycemic Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current automated insulin delivery systems assume a static insulin sensitivity factor, leading to inaccurate insulin dosing and failure to account for varying insulin effectiveness across different glycemic levels, resulting in either over- or under-administration of insulin.

Innovation Solution

A dynamic mathematical formula that calculates insulin sensitivity based on the patient's total daily insulin dose, basal to bolus insulin ratio, and the time it takes for the insulin to reach peak concentration, allowing for more accurate dosing adjustments.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If a static insulin sensitivity factor is used in automated insulin delivery systems, then the system operation is simple and device complexity is reduced, but the dosing accuracy deteriorates and glycemic control precision worsens due to failure to account for varying insulin effectiveness at different glycemic levels

Engineering Contradiction:
Improvesystem operation simplicityVSAvoiddosing accuracy
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent transforms the static insulin sensitivity factor into a dynamic calculation that adapts to varying glycemic conditions. The system now calculates insulin sensitivity factors based on current blood glucose levels, insulin-on-board data, and patient-specific parameters, allowing the dosing algorithm to adjust automatically to changing physiological states and improve dosing accuracy without requiring complex manual intervention

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent changes the parameter of insulin sensitivity from a fixed constant to a variable that changes based on glycemic level and insulin-on-board status. By implementing a calculation that adjusts the sensitivity factor in real-time based on current glucose readings and recent insulin administration history, the system achieves more precise dosing while maintaining automated operation

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If a static insulin sensitivity factor is assumed, then the calculation method is simple and ease of operation is improved, but the reliability of insulin dosing deteriorates due to over- or under-administration of insulin

Engineering Contradiction:
Improvecalculation simplicityVSAvoiddosing reliability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent implements feedback mechanisms where the system continuously monitors blood glucose levels, insulin administration history, and calculated sensitivity factors. This feedback loop allows the system to adjust future dosing recommendations based on actual glycemic responses to previous insulin administrations, improving reliability by learning from and adapting to individual patient responses while maintaining automated calculation

Inventive Principle:
Principle #23Feedback

3Ease of manufacture

If insulin sensitivity is treated as constant, then the model complexity is reduced and ease of manufacture is improved, but the adaptability to varying glycemic conditions deteriorates

Engineering Contradiction:
Improvemodel simplicityVSAvoidadaptability to glycemic variations
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The patent makes the insulin sensitivity model dynamic by incorporating real-time glycemic data and insulin-on-board information into the sensitivity calculation. This allows the model to adapt to varying glycemic conditions and insulin effectiveness at different glucose levels, improving versatility while maintaining automated calculation through standardized algorithms that can be implemented in existing pump software

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS20220359054A1Calculation of Insulin Sensitivity Factors used to determine correction doses of insulin at varying levels of glycemia in human patients.
Publication Date: 2022.11.10 WILSON CHRISTOPHER RICHARD
  • US20220359054A1 patent drawing

AI summary

This invention discloses a method of calculating insulin sensitivity factors for use in calculating insulin doses dynamically as a function of current blood glucose level based on a temporally-weighted average of the patient's total daily insulin dose, the pharmacodynamic and/or pharmacokinetic profile of the insulin used, and the patient's typical ratio of basal insulin to bolus insulin. When average total daily insulin and the other relevant variables are inserted into the equation, the result is a mathematical function that can be used to estimate the effects of each unit of insulin delivered on a patient's blood glucose level. This mathematical equation is valid over a wide range of diabetic conditions and could be widely used throughout the world at very little cost (and at considerable improvement) to the current technology in use for these purposes.